Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Gross Profit (2016 - 2025)

Apyx Medical's Gross Profit history spans 15 years, with the latest figure at $12.0 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 33.86% year-over-year to $12.0 million; the TTM value through Dec 2025 reached $33.0 million, up 12.55%, while the annual FY2025 figure was $33.0 million, 12.55% up from the prior year.
  • Gross Profit reached $12.0 million in Q4 2025 per APYX's latest filing, up from $8.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $12.2 million in Q4 2021 to a low of $5.7 million in Q1 2025.
  • Average Gross Profit over 5 years is $7.9 million, with a median of $7.8 million recorded in 2023.
  • Peak YoY movement for Gross Profit: skyrocketed 259.79% in 2021, then crashed 32.18% in 2022.
  • A 5-year view of Gross Profit shows it stood at $12.2 million in 2021, then tumbled by 32.18% to $8.2 million in 2022, then grew by 8.35% to $8.9 million in 2023, then grew by 0.39% to $9.0 million in 2024, then skyrocketed by 33.86% to $12.0 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Gross Profit are $12.0 million (Q4 2025), $8.3 million (Q3 2025), and $7.1 million (Q2 2025).